3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Neoplasms
3
Lung Neoplasms
2
Chronic Disease
2
Urinary Bladder Neoplasms
1
This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting.
1
Stress Disorders, Post-Traumatic
1
Parkinson Disease
1
Pancreatic Neoplasms
1
Pain, Intractable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Non Metastatic Rectal Cancer
1
Neoplasms, Second Primary
1
Muscle Spasticity
1
Multiple Sclerosis
1
Invasive Aspergillosis
1
Inflammatory Bowel Diseases
1
Immunoglobulin Light-chain Amyloidosis
1
Huntington Disease
1
Head and Neck Neoplasms
1
Glaucoma
1
Epilepsy
1
Dyskinesias
1
Colonic Neoplasms
1
Autism Spectrum Disorder
1
Anemia, Sickle Cell
1
Adenocarcinoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Surveys and Questionnaires
9
Cystectomy
6
Blood Specimen Collection
5
Neoadjuvant Therapy
4
Cystoscopy
4
Drug Therapy
3
avelumab
2
Urination
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pioglitazone
2
Microarray Analysis
2
Methods
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Immunohistochemistry
2
Defecation
2
Biopsy
2
5-aminolevulinic acid hexyl ester
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
erdafitinib
1
enfortumab vedotin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Urinary Sediment Analysis
1
Therapeutics
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Urinary Bladder Neoplasms
×
Registries
×
Clear all
NCT03413982
2026-03-10
GUB-BCR-001
University of Kansas Medical Center
Recruiting
1,000 enrolled